X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (367) 367
Publication (44) 44
Patent (11) 11
Book / eBook (8) 8
Book Chapter (7) 7
Dissertation (3) 3
Book Review (2) 2
Conference Proceeding (2) 2
Government Document (2) 2
Magazine Article (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (211) 211
female (178) 178
oncology (155) 155
index medicus (130) 130
breast neoplasms - drug therapy (105) 105
breast cancer (103) 103
middle aged (91) 91
breast neoplasms - pathology (85) 85
aged (82) 82
adult (80) 80
trastuzumab (76) 76
chemotherapy (63) 63
cancer (55) 55
breast neoplasms - metabolism (50) 50
antibodies, monoclonal, humanized (47) 47
treatment outcome (43) 43
receptor, erbb-2 - metabolism (41) 41
prognosis (40) 40
therapy (40) 40
antineoplastic agents - therapeutic use (39) 39
research (39) 39
animals (38) 38
breast neoplasms - genetics (38) 38
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
male (34) 34
monoclonal-antibody (34) 34
survival (34) 34
her2 (32) 32
risk factors (31) 31
article (30) 30
care and treatment (30) 30
phase-ii (30) 30
diagnosis (28) 28
medicine & public health (28) 28
metastasis (28) 28
antibodies, monoclonal - therapeutic use (27) 27
antineoplastic agents - pharmacology (27) 27
neoplasm staging (26) 26
skin and connective tissue diseases (25) 25
aged, 80 and over (24) 24
analysis (23) 23
drug resistance, neoplasm (23) 23
retrospective studies (23) 23
cell line, tumor (22) 22
health aspects (22) 22
breast neoplasms - mortality (21) 21
identification (21) 21
antibodies, monoclonal - pharmacology (20) 20
surgery (20) 20
survival analysis (20) 20
tumors (20) 20
carcinoma (19) 19
cells (19) 19
immunohistochemistry (19) 19
receptor, erbb-2 - genetics (19) 19
apoptosis (18) 18
disease-free survival (18) 18
mice (18) 18
neoadjuvant therapy (18) 18
signal transduction (18) 18
adjuvant chemotherapy (17) 17
chemotherapy, adjuvant (17) 17
drug therapy (17) 17
neoplasm metastasis (17) 17
time factors (17) 17
expression (16) 16
gene expression (16) 16
gene expression regulation, neoplastic (16) 16
microbiology (16) 16
patient outcomes (16) 16
receptor, erbb-2 - analysis (16) 16
spain (16) 16
biochemistry (15) 15
development and progression (15) 15
efficacy (15) 15
genetic aspects (15) 15
resistance (15) 15
breast neoplasm (14) 14
breast neoplasms - therapy (14) 14
clinical trials (14) 14
disease progression (14) 14
epidemiology (14) 14
neoplasms (14) 14
adolescent (13) 13
antibodies, monoclonal - administration & dosage (13) 13
biomarkers (13) 13
biomarkers, tumor - analysis (13) 13
clinical trials as topic (13) 13
medical research (13) 13
medicine (13) 13
metastatic breast-cancer (13) 13
physiological aspects (13) 13
predictive value of tests (13) 13
research article (13) 13
survival rate (13) 13
breast neoplasms - chemistry (12) 12
epidermal growth factor (12) 12
erbb-2 protein (12) 12
internal medicine (12) 12
mortality (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 03/2019, Volume 20, Issue 3, pp. e175 - e186
Immunotherapy is emerging as a new treatment modality in breast cancer. After long-standing use of endocrine therapy and targeted biological therapy, improved... 
TUMOR-INFILTRATING LYMPHOCYTES | CELL CYTOTOXICITY | NEOADJUVANT CHEMOTHERAPY | TRASTUZUMAB | MICROENVIRONMENT | ONCOLOGY | BEVACIZUMAB | PD-L1 EXPRESSION | PHASE-II | ABEMACICLIB | PROGNOSTIC VALUE | Medical colleges | Chemotherapy | Biological products | Immunotherapy | Monoclonal antibodies | Breast cancer | Metastasis | Angiogenesis inhibitors | Sugars | Cancer | Monosaccharides
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 10/2019, Volume 19, Issue 10, pp. 987 - 992
Introduction: CT-P6 (trastuzumab-pkrb, Herzuma) is a trastuzumab biosimilar approved for use in HER2 positive breast cancer and HER2 positive gastric cancer.... 
trastuzumab | HER2 | Breast neoplasm | biosimilar | Index Medicus
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2019, Volume 176, Issue 3, pp. 687 - 696
The metabolic etiology of breast cancer has been explored in the past several years using metabolomics. However, most of these studies only included... 
Metabolomics | Oncology | Racial minority | Breast cancer | Medicine & Public Health | ONCOLOGY | DISEASE | BODY-MASS INDEX | FATTY-ACIDS | ALBUMIN | IDENTIFICATION | METABOLOMIC PROFILES | SERUM BILIRUBIN | Unsaturated fatty acids | Metabolites | Oncology, Experimental | Physiological aspects | Development and progression | Research | Risk factors | African American women | Cancer
Journal Article
Cancer Research, ISSN 0008-5472, 06/2004, Volume 64, Issue 11, pp. 3981 - 3986
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2019, Volume 176, Issue 3, pp. 697 - 697
In the original publication of the article, the sixth author name Krita A. Zanetti was mistakenly included as co-author. The corrected author group is given in... 
Medicine & Public Health | Oncology | Breast cancer | Metabolites | Epidemiology | Risk factors | African American women
Journal Article
by Callejas, Raquel and Panadero, Alfredo and Vives, Marc and Duque, Paula and Echarri, Gemma and Monedero, Pablo and Acedo, Guadalupe and Agudo, Óscar and Aguilar, Gerardo and Albacete, Carlos L and Alonso, Sara and Álvarez, Emilio and Álvarez, Felisa and Álvarez-Fuente, Elisa and Amaya, Jenny F and Angulo, José M and Arocas, Blanca and Arribas, Pilar and Arteta, Maite and Ávila, Elisa and Badenes, Rafael and Ballester, Juan A and Baños, Gerardo and Barado, Julio and Barrios, José M and Barrios, Rosa and Belda, F. Javier and Belda, Isabel and Berastegui, Elisabet and Bixquert, David and Burgos, Virginia and Bustamante, Cintia and Calderón, Enrique and Campos, Ana and Candela, Ángel and Canteli, Ángela and Carbonell, José A and Carnero, Dionisio and Carrasco, María D and Casas, Raquel and Castaño, Beatriz and Cobo, Manuel and Cordón, Sara and Depablo, Angélica and Domínguez, María-Jesús and Elías, Elena and Esteva, Carlos and Fernández, Feliciano and Fernández, Félix E and Fernández, Laura and Fernando, Carlos and Flores, Juan B and Gajate, Luis and Galán, Manuel and García, Álvaro and García, Carolina and García, Manuela and García-Fernández, Nuria and García-Márquez, Carlos and Garcipérez, J. Francisco and Gómez, Aurelio and Gómez, Alba and Gómez, Aroa and González, Francisco J and González, Raquel and Gragera, Isabel and Guerrero, José and Herrador, Paloma and Ibáñez, Sonia and Iglesias, Lisardo and Jara, Rubén and Just, Soledad and Llano, Miguel F and López, Alexo and Manciño, José M and Martínez, Marcos and Mateos, Blanca and Matute, Purificación and Misis, María T and Navarro, Isabel and Novoa, Emma and Níñez, Mercedes and Olmos, Miguel and Paredes, Isidro and Parise, Diego and Pastor, Ernesto and Pereira, Jorge and Pereira, Miguel Á and Peris, Xavier and Pita-Romero, Rafael and Porro, Jesús and Prada, Beatriz and Puerto, Laura-Mercedes and Puig, Jaume and Ricart, Pilar and Roma, Francesc and Román, Adriana and Roux, Carmen and Royuela, Natalia and Ruiz, Marta and ... and Renal Dysfunction Cardiac Surg Spa and Renal Dysfunction in Cardiac Surgery Spanish Group (GEDRCC2)
Minerva Anestesiologica, ISSN 0375-9393, 01/2019, Volume 85, Issue 1, pp. 34 - 44
BACKGROUND: Predictive models of acute kidney injury after cardiac surgery (CS-AKI) include emergency surgery and patients with hemodynamic instability. Our... 
Cardiac surgical procedures | Elective surgical procedures | Statistical models | Acute kidney injury | Risk factors | CARDIOTHORACIC SURGERY | RISK | EXTERNAL VALIDATION | MINIMAL CHANGES | FAILURE REQUIRING DIALYSIS | SERUM CREATININE | BIOMARKERS | SCORES | ANESTHESIOLOGY | INDEX | RENAL REPLACEMENT THERAPY | CRITICAL CARE MEDICINE
Journal Article
Oncology Times, ISSN 0276-2234, 12/2018, Volume 40, Issue 24, pp. 36 - 37
Journal Article
Future Oncology, ISSN 1479-6694, 10/2018, Volume 14, Issue 25, pp. 2651 - 2661
Triple negative breast cancer (TNBC) is a heterogeneous disease that comprises 15-20% of all breast cancers and is more frequently seen in younger women,... 
breast neoplasm | biological | drug delivery | SACITUZUMAB GOVITECAN IMMU-132 | BRENTUXIMAB VEDOTIN | CLINICAL-FEATURES | GLEMBATUMUMAB VEDOTIN | EPITHELIAL-MESENCHYMAL TRANSITION | TUMOR-INFILTRATING LYMPHOCYTES | ONCOLOGY | RANDOMIZED PHASE-II | THERAPEUTIC TARGET | ESTROGEN | GLYCOPROTEIN NONMETASTATIC B
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. TPS1124 - TPS1124
Journal Article
Expert opinion on biological therapy, 09/2019, p. 1
: CT-P6 (trastuzumab-pkrb, Herzuma) is a trastuzumab biosimilar approved for use in HER2 positive breast cancer and HER2 positive gastric cancer. CT-P6 has... 
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 16, pp. 12868 - 12878
MicroRNAs have been shown to play important roles in breast cancer progression and can serve as biomarkers. To assess the prognostic role of a panel of miRNAs... 
Gene expression profiling | Breast cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.